v3.22.2.2
Commitments and Contingencies (Details 2) - Equity Option [Member]
12 Months Ended
Sep. 30, 2022
USD ($)
$ / shares
shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Options Outstanding at beginning | shares 11,330,903
Weighted Average Exercise Price Outstanding at beginning $ 5.74
Aggregate intrinsic value Outstanding at beginning | $ $ 140,132,451
Options Granted | shares 2,358,000
Weighted Average Exercise Price Granted $ 10.13
Weighted Average Grant Date Fair Value Granted $ 7.07
Options Forfeited | shares (118,750)
Weighted Average Exercise Price Forfeited $ 6.86
Weighted Average Grant Date Fair Value Forfeited $ 5.23
Options Exercised | shares (400,537)
Weighted Average Exercise Price Exercised $ 2.52
Weighted Average Grant Date Fair Value Exercised $ 1.88
Aggregate intrinsic value Exercised | $ $ 4,201,015
Options Outstanding at ending | shares 13,169,616
Weighted Average Exercise Price Outstanding at ending $ 6.61
Aggregate intrinsic value Outstanding at ending | $ $ 62,267,309
Options Exercisable at ending | shares 8,777,113
Weighted Average Exercise Price Exercisable at ending $ 4.40
Aggregate intrinsic value Exercisable at ending | $ $ 55,173,997